Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SZSE: 301584)
Health Care · Health Care Providers & Services · CN
CN¥18.53
-5.99% today · -34.2% 1Y
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SZSE: 301584) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.16B.
Over the last twelve months the share price has lost 34.2%, trading between 17.90 and 40.80.
Tweenvest scores Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. across four factors: quality 58/100, value 77/100, growth 78/100, dividend 23/100. Its strongest factor is growth.
301584 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.16B
- Revenue (TTM)
- $2.82B
- P/E
- 25.99
- EPS
- 0.71
- Dividend yield
- 1.08%
- Beta (5Y)
- —
- 52-week high
- CN¥40.80
- 52-week low
- CN¥17.90
- Avg volume (3M)
- —
- Shares outstanding
- 421.29M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| H.U. Group Holdings, Inc.TSE: 4544 | $1.20B | ¥3,445.00 | -4.31% |
| Ramsay Générale de Santé SAENXTPA: GDS | $1.20B | €9.96 | +2.89% |
| Raffles Medical Group LtdSGX: BSL | $1.18B | S$0.82 | -0.61% |
| Nanjing Xinjiekou Department Store Co., Ltd.SHSE: 600682 | $1.17B | CN¥5.84 | +1.39% |
| Metropolis Healthcare LimitedNSEI: METROPOLIS | $1.16B | Rs537.90 | -7.67% |
| Genertec Universal Medical Group Company LimitedSEHK: 2666 | $1.16B | HK$4.51 | +0.78% |
| Uniphar plcISE: UPR | $1.15B | €3.95 | +0.51% |
| INKON Life Technology Co., Ltd.SZSE: 300143 | $1.13B | CN¥7.85 | +0.51% |
Figures last refreshed Oct 4, 2026.